人福医药：公司的治疗用生物制品1类新药重组质粒-肝细胞生长因子注射液已完成生产现场核查及临床现场核查

Group 1 - The company, Renfu Pharmaceutical, has completed the production site inspection and clinical site inspection for its Class 1 new drug, recombinant plasmid-hepatocyte growth factor injection, indicating that the project is progressing normally [1]